Drug Database
Back to search

Italy· 028330037

AKINETON*50 cpr 4 mg rilascio prolungato

A biperiden product containing biperidene, registered in Italy by SIT LABORATORIO FARMAC. Srl, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC N04AA02

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedAKINETON*50 cpr 4 mg rilascio prolung…ATCN04AA02REGISTER NO.028330037PACKS LISTED1CHECKEDJune 4, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about biperideneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Biperiden is registered in 15 of 19 countries.

Countries holding a registration under ATC N04AA02 (biperiden), each read from that country’s own register.

  • This record: Italy
  • 9 of them publish a price we can compare per daily dose
Search biperiden products by name

Biperiden · ATC N04AA02

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of biperiden costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.28 in France to $1.58 in Switzerland — a ×5.7 gap.

  • Italy: $0.36 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Biperiden · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.58
  • IT Italy$0.36
  • FR France$0.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Active substance
Biperidene
Manufacturer
SIT LABORATORIO FARMAC. Srl
Country
Italy (IT)
ATC code
N04AA02
ATC class
Biperiden
Defined daily dose
10 mg, O
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    028330037
    AKINETON*50 cpr 4 mg rilascio prolungato
    EUR 5.33

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

89 interactions on record for biperiden.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check biperiden against other medicinesHow interaction checks work

Biperiden · interactions on record

89 records

  • 3 severe
  • 85 moderate
  • 1 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DicycloverineA03AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Biperiden in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All biperiden products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Akineton
  • Belgium · Akineton
  • Bulgaria · Акинестат, Акинетон
  • Cyprus · Akineton Retard
  • Czechia · Akineton
  • Germany · Akineton, Biperiden Neuraxpharm
  • Denmark · Akineton
  • Spain · Akinetón, Akinetón Retard
  • Finland · Akineton
  • France · Akineton L.P.
  • Greece · Akineton
  • Croatia · Akineton, Mendilex
  • Hungary · Akineton
  • Ireland · Akineton, Akineton Retard
  • Iceland · Akineton
  • Luxembourg · Akineton
  • Netherlands · Akineton
  • Norway · Akineton
  • Poland · Akineton, Akineton Sr
  • Portugal · Akineton, Akineton Retard
  • Sweden · Akineton
  • Slovenia · Akineton
  • Slovakia · Akineton, Akineton Sr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed2d309c-6720-4d7a-a6c1-e64bb8ab7558
GET /v1/drugs/ed2d309c-6720-4d7a-a6c1-e64bb8ab7558?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 5.33,
  "source": "aifa",
  "currency": "EUR",
  "strength": "BIPERIDENE 4MG 50 UNITA' USO ORALE RP",
  "substance": "Biperidene",
  "equivalence_group": "I7B",
  "transparency_flag": null
}
API referenceMCP serverPlans

See everything about biperiden.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console